Thalidomide and neomycin are among the familiar drugs that are now being investigated for new applications in the treatment of disease. Viagra and minoxidil among the drugs that became more widely used for their “side” effects than for the primary effect for which they were developed. A panel talks about drug research — how scientists identify new uses for known drugs, and how they’re tested and marketed.


  • Dr. James M. Pluda Senior clinical investigator in the Investigational Drug Branch of the National Cancer Institute
  • Dr. Jillian Woollett Associate vice president for biotechnology and biologics at Pharmaceutical Reserach and Manufacturers of America
  • Dr. Robert Temple Of the FDA


comments powered by Disqus
Most Recent Shows

The Tuskegee Study, 50 Years Later

Friday, Jul 29 2022Fifty years after the Tuskegee study, Diane talks to Harvard's Evelynn Hammonds about the intersection of race and medicine in the United States, and the lessons from history that can help us understand health inequities today.